Pharming Group N.V. (AMS: PHARM)
Netherlands
· Delayed Price · Currency is EUR 0.861
+0.006 (0.70%)
Jan 30, 2025, 3:05 PM CET
Pharming Group Ratios and Metrics
Market cap in millions EUR. Fiscal year is January - December.
Millions EUR. Fiscal year is Jan - Dec.
Fiscal Year | Current | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 - 2014 |
|---|---|---|---|---|---|---|---|
Period Ending | Jan '25 Jan 30, 2025 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Jan '20 Jan 1, 2020 | 2019 - 2015 |
| Market Capitalization | 588 | 690 | 707 | 503 | 812 | 990 | Upgrade
|
| Market Cap Growth | -36.48% | -2.41% | 40.66% | -38.05% | -17.99% | 110.20% | Upgrade
|
| Enterprise Value | 548 | 658 | 657 | 487 | 787 | 987 | Upgrade
|
| Last Close Price | 0.86 | 1.03 | 1.08 | 0.78 | 1.27 | 1.57 | Upgrade
|
| PE Ratio | - | - | 55.27 | 35.75 | 26.30 | 27.26 | Upgrade
|
| Forward PE | - | 163.65 | 27.10 | 16.92 | 15.76 | 19.35 | Upgrade
|
| PS Ratio | 2.20 | 3.11 | 3.68 | 2.88 | 4.68 | 5.84 | Upgrade
|
| PB Ratio | 2.21 | 3.49 | 3.69 | 2.96 | 5.41 | 9.42 | Upgrade
|
| P/TBV Ratio | 3.58 | 5.17 | 5.82 | 5.23 | 10.47 | 25.82 | Upgrade
|
| P/FCF Ratio | - | - | 35.85 | 21.10 | 12.57 | 15.46 | Upgrade
|
| P/OCF Ratio | 1258.18 | - | 33.65 | 15.11 | 11.87 | 14.91 | Upgrade
|
| EV/Sales Ratio | 2.14 | 2.97 | 3.41 | 2.78 | 4.54 | 5.82 | Upgrade
|
| EV/EBITDA Ratio | - | - | 44.16 | 18.22 | 11.66 | 15.23 | Upgrade
|
| EV/EBIT Ratio | - | - | 67.70 | 23.07 | 12.62 | 16.36 | Upgrade
|
| EV/FCF Ratio | -1192.30 | - | 33.29 | 20.43 | 12.19 | 15.42 | Upgrade
|
| Debt / Equity Ratio | 0.56 | 0.78 | 0.81 | 0.84 | 0.88 | 0.50 | Upgrade
|
| Debt / EBITDA Ratio | 209.36 | - | 9.03 | 4.88 | 1.92 | 0.79 | Upgrade
|
| Debt / FCF Ratio | - | - | 7.91 | 5.97 | 2.05 | 0.81 | Upgrade
|
| Asset Turnover | 0.66 | 0.55 | 0.50 | 0.49 | 0.63 | 0.76 | Upgrade
|
| Inventory Turnover | 0.52 | 0.51 | 0.50 | 0.87 | 1.26 | 1.35 | Upgrade
|
| Quick Ratio | 2.76 | 3.28 | 3.90 | 4.69 | 3.08 | 0.90 | Upgrade
|
| Current Ratio | 3.53 | 4.06 | 4.65 | 5.33 | 3.43 | 1.05 | Upgrade
|
| Return on Equity (ROE) | -8.18% | -4.98% | 6.88% | 8.50% | 25.10% | 43.52% | Upgrade
|
| Return on Assets (ROA) | -1.38% | -3.06% | 1.57% | 3.68% | 14.13% | 17.01% | Upgrade
|
| Return on Capital (ROIC) | -1.64% | -3.57% | 1.78% | 4.29% | 18.30% | 25.85% | Upgrade
|
| Return on Capital Employed (ROCE) | - | - | 2.83% | 6.85% | 22.32% | 47.60% | Upgrade
|
| Earnings Yield | -2.72% | -1.38% | 1.81% | 2.80% | 3.80% | 3.67% | Upgrade
|
| FCF Yield | -0.08% | -2.46% | 2.79% | 4.74% | 7.95% | 6.47% | Upgrade
|
| Buyback Yield / Dilution | 1.41% | 7.09% | -0.85% | -2.70% | -1.37% | -3.06% | Upgrade
|
| Total Shareholder Return | 1.41% | 7.09% | -0.85% | -2.70% | -1.37% | -3.06% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.